Skip to main content

Black Diamond Therapeutics

Cambridge, United States

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

$75.0M raised
Jun 2023
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Black Diamond Therapeutics

How much funding has Black Diamond Therapeutics raised?
Black Diamond Therapeutics has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2023.
Who are Black Diamond Therapeutics's investors?
Black Diamond Therapeutics's investors include RA Capital Management, Wellington Management, Janus Henderson Investors, New Enterprise Associates, Perceptive Advisors.
Where is Black Diamond Therapeutics headquartered?
Black Diamond Therapeutics is headquartered in Cambridge, United States.
What does Black Diamond Therapeutics do?
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
What stage is Black Diamond Therapeutics at?
Black Diamond Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Black Diamond Therapeutics — Funding & Investors." VCBacked, June 29, 2023, https://www.vcbacked.co/company/black-diamond-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Black Diamond Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/black-diamond-therapeutics
Wikipedia (cite web)
{{cite web |title=Black Diamond Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/black-diamond-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .